Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Among infants and children hospitalized in Kenya with severe pneumonia, respiratory syncytial virus appears to be the predominant virus detected, according to a study in the May 26 issue of JAMA.

26 May 2010

Workplace wellness programs improve employer's bottom line

"Who has time?" is a frequent question in response to the suggestion of a medical check-up. Job demands aren't becoming easier to meet in this challenging economy. And there is always a "to-do" list waiting at home. Naturally employees feel these pressures.

26 May 2010

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Older patients battling pneumonia spent less time in the hospital when treated using osteopathic manipulative medicine - a drug-free form of hands-on medical care focusing on increasing muscle motion - in addition to conventional care, recently published research shows.

26 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

Vision Chain, Inc., the leading global provider of demand signal repository and predictive analytic solutions, announced today that Bayer Healthcare LLC, the global leader in trusted brands for healthcare and nutrition, has licensed its technology platform to analyze store-specific sales, assortments, prices, promotions and other factors to optimize go-to-market efforts with multiple retailers.

25 May 2010

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that the supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence has been designated a priority review by the U.S. Food and Drug Administration (FDA).

25 May 2010

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.

25 May 2010

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

In a tropical environment, influenza A(H1N1) appeared milder than seasonal flu, was less likely to cause fever and upset stomach and more likely to infect younger individuals, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

Family of EPA-registered disinfecting products to be launched

An innovative family of EPA-registered disinfecting products will be launched through a new direct selling company, it was announced today.

25 May 2010

New research finding may change direction of vaccine research for M. tuberculosis

Scientists at NYU Langone Medical Center have discovered that the strategy of "immune evasion" common to many viruses, bacteria and parasites, is uncommon to M. tuberculosis where the antigens remain strikingly unchanged and homogenous. The study published in Nature Genetics on May 23, 2010, suggests that M. tuberculosis antigens do not mutate because they hope to be recognized by the body's immune system- perhaps because the host immune mechanism that leads to the typical lung destruction and cough can contribute to the spread of the disease.

25 May 2010

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

25 May 2010

Joint research by UB and CDC could lead to new generation of antiviral medicines

Future pandemics of seasonal flu, H1N1 and other drug-resistant viruses may be thwarted by a potent, immune-boosting payload that is effectively delivered to cells by gold nanorods, report scientists at the University at Buffalo and the U.S. Centers for Disease Control and Prevention. The work is published in the current issue of the Proceedings of the National Academy of Sciences.

25 May 2010

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.

25 May 2010

Researchers identify mechanisms involved in gene mutation

Genetic variation due to DNA mutation is a driving force of adaptation and evolution, as well as a contributing factor to disease. However, the mechanisms governing DNA mutation rate are not well understood.

25 May 2010

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Pregnant women who contract the H1N1 flu strain are at risk for obstetrical complications including fetal distress, premature delivery, emergency cesarean delivery and fetal death, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

FDA issues 510(k) clearance to Simplexa Influenza A H1N1 (2009) test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.

25 May 2010

FDA clears Simplexa Influenza A H1N1 (2009) test

The U.S. Food and Drug Administration today announced it has cleared the Simplexa Influenza A H1N1 (2009), a test for the 2009 H1N1 Influenza Virus in patients with signs and symptoms of respiratory infection.

24 May 2010

China Yongxin Pharmaceuticals first-quarter 2010 revenues increase 16.3% to $10.68M

China Yongxin Pharmaceuticals Inc., one of the leading health products distribution and retail sales companies in China, today announced its financial results for the first quarter ending March 31, 2010.

24 May 2010

NanoViricides reports $2.95M in cash, $305,000 in prepaid expenses for quarter ended March 31, 2010

NanoViricides, Inc., has filed its quarterly report with the Securities and Exchange Commission on Thursday, May 20th, in a timely fashion.

24 May 2010

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.

24 May 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Workplace wellness programs improve employer's bottom line

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

Family of EPA-registered disinfecting products to be launched

New research finding may change direction of vaccine research for M. tuberculosis

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Joint research by UB and CDC could lead to new generation of antiviral medicines

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

Researchers identify mechanisms involved in gene mutation

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

FDA issues 510(k) clearance to Simplexa Influenza A H1N1 (2009) test on 3M Integrated Cycler

FDA clears Simplexa Influenza A H1N1 (2009) test

China Yongxin Pharmaceuticals first-quarter 2010 revenues increase 16.3% to $10.68M

NanoViricides reports $2.95M in cash, $305,000 in prepaid expenses for quarter ended March 31, 2010

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in